Hanmi Pharmaceutical : Once-Weekly Insulin Combination, ‘LAPSInsulin Combo … – Business Wire (press release)

Hanmi Pharmaceutical : Once-Weekly Insulin Combination, ‘LAPSInsulin Combo
Business Wire (press release)
SEOUL, South Korea–(BUSINESS WIRE)–Hanmi Pharmaceutical Co., Ltd.(KSE: 128940) made an oral presentation on the non-clinical results of once weekly insulin and GLP-1 combination drug ‘LAPSInsulin Combo’ at the 75th American DiabetesĀ …

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd